Brief: Mei Pharma And Kyowa Kirin Announce Acceptance Of Abstract For Presentation At American Society Of Clinical Oncology Annual Meeting 2022
27/05/2022 24:42
May 26 (Reuters) - Kyowa Kirin Co Ltd 4151.T :
* MEI PHARMA AND KYOWA KIRIN ANNOUNCE ACCEPTANCE OF ABSTRACT
FOR
PRESENTATION AT AMERICAN SOCIETY OF CLINICAL ONCOLOGY ANNUAL
MEETING 2022
Source text for Eikon: ID:nBwhhLY7a
Further company coverage: 4151.T
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kyowa Kirin
See all newsFactbox: Global pharma companies that have publicly announced Trump drug pricing agreements
Factbox: Global pharma companies that have publicly announced Trump drug pricing agreements
Brief: Kyowa Kirin Announces Agreement With US Administration To Reduce Treatment Costs For Americans
Table: Kyowa Kirin 6-MTH group results (IFRS)
Brief: Kyowa Kirin Says European Commission Approves Crysvita For Infants With X-Linked Hypophosphataemia